Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 15 04:00PM ET
37.00
Dollar change
+0.54
Percentage change
1.48
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y0.61% Shs Outstand Perf Week2.24%
SponsorPrincipal Financial Services ETF Type Tagsequity Return% 3Y-10.72% Total Holdings270 Perf Month6.32%
Fund Family Bond Type Tagshealthcare Return% 5Y3.39% AUM38.98M Perf Quarter-1.02%
Index- Average Maturity Tagspharmaceutical Return% 10Y NAV% Perf Half Y38.50%
Index Weighting Commodity Type Tagsbiotechnology Return% SI NAV/sh Perf Year-0.91%
Active/Passive Quant Type Tagsinnovation Flows% 1M-8.02% 52W Range25.66 - 39.75 Perf YTD1.84%
Dividend TTM- ESG Type Tags- Flows% 3M-18.20% 52W High-6.92% Beta1.00
Dividend Ex-DateDec 29, 2021 Dividend Type Sector/Theme Flows% YTD-20.62% 52W Low44.19% ATR (14)0.60
Expense0.42% Structure Type Region Flows% 1Y RSI (14)57.78 Volatility0.32% 0.82%
Option/ShortNo / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.09 Prev Close36.46
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume5.33K Price37.00
SMA204.80% SMA501.59% SMA20010.06% Trades Volume482 Change1.48%
Jan-26-22 09:38AM
May-12-21 04:45PM
12:00PM
Aug-20-20 05:25PM
Jul-16-20 04:51PM
01:41PM Loading…
Dec-18-19 01:41PM
Dec-02-19 02:40PM
Oct-23-19 10:10AM
Sep-03-19 05:46PM
Jun-24-19 04:23PM
Apr-11-19 03:33PM
Apr-05-19 08:00AM
Apr-02-19 10:00AM
Mar-12-19 11:05AM
Mar-04-19 11:05AM
01:00PM Loading…
Feb-28-19 01:00PM
Feb-27-19 03:00PM
Feb-14-19 10:05AM
Jan-24-19 01:00PM
Mar-01-17 08:59AM
Aug-31-16 09:00AM
Aug-25-16 10:55AM
Aug-23-16 04:04PM
Aug-22-16 04:15PM
12:05PM
Principal Healthcare Innovators ETF seeks long-term growth of capital. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies in the healthcare sector. It invests significantly in early-stage companies within the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries that are not yet consistently profitable.